Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

American Vanguard Reports Fourth Quarter & Full Year 2015 Results

AVD

American Vanguard Corporation (NYSE:AVD) today announced financial results for the fourth quarter and full year ended December 31, 2015.

Fiscal 2015 Fourth Quarter Financial Highlights – versus Fiscal 2014 Fourth Quarter:

  • Net sales were $84.0 million in Q4 2015 compared to $77.6 million in Q4 2014.
  • Net income was $3.0 million in Q4 2015 compared to $1.8 million in Q4 2014.
  • Earnings per diluted share were $0.10 in Q4 2015 versus $0.06 in Q4 2014.

Fiscal 2015 Financial Highlights – versus Fiscal 2014:

  • Net sales were $289.4 million in FY 2015 compared to $298.6 million in FY 2014.
  • Net income was $6.6 million in FY 2015 compared to $4.8 million in FY 2014.
  • Earnings per diluted share were $0.23 in FY 2015 versus $0.17 in FY 2014.

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “Our performance in 2015 reflects continued financial discipline in the face of difficult industry conditions. Low crop commodity prices have led to reduced farmer/grower profitability and cautious purchasing of all crop inputs, including crop protection products. Despite these market conditions, during 2015, American Vanguard recorded net sales only slightly below those of the prior year, maintained a steady level of business in many markets and generated improved profitability overall.”

Mr. Wintemute continued: “Our efforts to control working capital, manage manufacturing costs and reduce operating expenses have led to greater operating efficiency. As a result, we have experienced significant inventory reductions, improved cash generation and have reduced our debt, even while completing two acquisitions that should serve to strengthen our international business.”

Mr. Wintemute concluded: “While the Ag market prospects for 2016 remain challenging, American Vanguard is well-positioned, in a consolidating industry, to pursue its three main objectives: improving market access through additional product acquisitions and collaborative alliances; advancing technological innovation; and driving operational excellence. We believe that these will be the keys to our success and look forward to keeping our investors well informed as we progress in 2016.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele, EVP & COO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 4:30 pm ET / 1:30 pm PT on Tuesday, March 1, 2016. Interested parties may participate in the call by dialing (201) 493-6744. Please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

Years ended December 31, 2015, 2014 and 2013

(In thousands, except per share data)

         
2015 2014 2013
Net sales $ 289,382 $ 298,634 $ 381,021
Cost of sales   177,480     184,138     209,674  
 
Gross profit 111,902 114,496 171,347
Operating expenses   100,378     107,786     115,612  
 
Operating income 11,524 6,710 55,735
Interest expense, net 2,772 3,153 2,175
Interest capitalized   (210 )   (87 )   (274 )
 
Income before provision for income taxes and loss on equity investment 8,962 3,644 53,834
Income taxes expense (benefit)   2,009     (451 )   18,916  
 
Income before loss on equity investment 6,953 4,095 34,918
Less net loss from equity method investment   (636 )   (29 )   (986 )
 
Net income 6,317 4,066 33,932
Add back net loss attributable to non-controlling interest   274     775     517  
 
Net income attributable to American Vanguard $ 6,591   $ 4,841   $ 34,449  
 
Change in fair value of interest rate swaps 340 388
Foreign currency translation adjustment   (1,571 )   (1,262 )   326  
 
Comprehensive income $ 5,020   $ 3,919   $ 35,163  
 
Earnings per common share—basic $ .23   $ .17   $ 1.22  
 
Earnings per common share—assuming dilution $ .23   $ .17   $ 1.19  
 
Weighted average shares outstanding—basic   28,673     28,436     28,301  
 
Weighted average shares outstanding—assuming dilution   29,237     28,912     28,899  
 
 

CONSOLIDATED BALANCE SHEETS

December 31, 2015 and 2014

(In thousands, except share data)

       
2015 2014
Assets
Current assets:
Cash and cash equivalents $ 5,524 $ 4,885
Receivables:
Trade, net of allowance for doubtful accounts of $423 and $166, respectively 72,835 86,027
Other   2,554     2,396  
 
  75,389     88,423  
 
Inventories 136,477 165,631
Prepaid expenses 11,172 13,415
Income taxes receivable 168 5,964
Deferred income tax assets   8,101     8,731  
 
Total current assets 236,831 287,049
Property, plant and equipment, net 47,972 50,026
Intangible assets, net of applicable amortization 129,160 100,211
Other assets   29,576     35,035  
 
$ 443,539   $ 472,321  
 
Liabilities and Stockholders’ Equity
Current liabilities:
Current installments of other notes payable $ 55 $ 71
Current installments of other liabilities 514 1,357
Accounts payable 15,343 20,411
Deferred revenue 8,888 898
Accrued program costs 44,371 52,546
Accrued expenses and other payables   7,111     5,962  
 
Total current liabilities 76,282 81,245
Long-term debt and other notes payable, excluding current installments 68,321 98,605
Other liabilities, excluding current installments 3,054 3,309
Deferred income tax liabilities   27,556     28,159  
 
Total liabilities   175,213     211,318  
 
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 31,638,225 shares in 2015 and 31,550,477 shares in 2014 3,164 3,156
Additional paid-in capital 68,534 66,232
Accumulated other comprehensive loss (3,541 ) (1,970 )
Retained earnings   208,507     202,488  
 
276,664 269,906
Less treasury stock at cost, 2,450,634 shares in 2015 and in 2014   (8,269 )   (8,269 )
 
American Vanguard Corporation stockholders’ equity 268,395 261,637
Non-controlling interest   (69 )   (634 )
 
Total stockholders’ equity   268,326     261,003  
 
$ 443,539   $ 472,321  
 
 

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2015, 2014 and 2013

(In thousands)

         
2015 2014 2013
Increase cash
Cash flows from operating activities:
Net income $ 6,317 $ 4,066 $ 33,932
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization of fixed and intangible assets 16,474 16,332 14,845
Amortization of other long term assets 5,275 5,811 4,598
Amortization of discounted liabilities 140 324 174
Stock-based compensation 3,881 4,153 3,819
Tax effect from the share based compensation (23 ) (300 ) (440 )
Increase in deferred income taxes 27 2,619 2,523
Operating loss from equity method investment 629 983 986
Loss (gain) from dilution of equity method investment 7 (954 )
Changes in assets and liabilities associated with operations:
Decrease (increase) in net receivables 13,034 (13,471 ) 2,351
Decrease (increase) in inventories 29,154 (25,801 ) (51,879 )
Decrease (increase) in income tax receivable/payable, net 4,872 4,424 (10,961 )
Decrease (increase) in prepaid expenses and other assets 2,082 (4,743 ) (19,733 )
(Decrease) increase in accounts payable (5,068 ) (19,951 ) 8,252
Increase (decrease) in deferred revenue 7,990 (2,890 ) (16,639 )
(Decrease) increase in other payables, accrued program costs and expenses   (6,223 )   (4,697 )   21,958  
 
Net cash provided by (used in) operating activities   78,568     (34,095 )   (6,214 )
 
Cash flows from investing activities:
Capital expenditures (6,899 ) (7,180 ) (15,260 )
Investment (125 ) (500 ) (3,687 )
Acquisitions of intangible assets   (36,667 )        
 
Net cash used in investing activities   (43,691 )   (7,680 )   (18,947 )
 
Cash flows from financing activities:
Net (payments) borrowings under line of credit agreement (30,520 ) 47,850 51,550
Payments on long-term debt (46,000 )
Payment on other long-term liabilities (1,543 ) (1,756 ) (1,831 )
Tax effect from the share based compensation 23 300 440
Decrease in other notes payable (6,154 )
Repurchases of common stock (1,531 ) (1,934 )
Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock options) 317 1,666 1,610
Non-controlling interest contribution 299
Payment of cash dividends   (1,141 )   (5,672 )   (4,804 )
 
Net cash (used in) provided by financing activities   (32,864 )   41,156     (7,123 )
 
Net increase (decrease) in cash and cash equivalents 2,013 (619 ) (32,284 )
Effect of exchange rate changes on cash (1,374 ) (1,176 ) 488
Cash and cash equivalents at beginning of year   4,885     6,680     38,476  
 
Cash and cash equivalents at end of year $ 5,524   $ 4,885   $ 6,680  
 
Supplemental cash flow information:
Cash paid (received) during the year for:
Interest $ 2,750   $ 2,298   $ 1,777  
 
Income taxes $ (3,697 ) $ (8,206 ) $ 25,271  

Company:
American Vanguard Corporation
William A. Kuser, 949-260-1200
Director of Investor Relations
williamk@amvac-chemical.com
or
Investor Representative
The Equity Group Inc.
Lena Cati, 212-836-9611
Lcati@equityny.com
www.theequitygroup.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today